Literature DB >> 20234353

Treatment of painful bone metastases.

Dirk Rades1, Steven E Schild, Janet L Abrahm.   

Abstract

Bone metastases are the most common cause of cancer-related pain. Radiotherapy is a safe and effective therapy and is well established for such a situation. A fractionation regimen with a short overall treatment time (< or =1 week) would be preferred if it was as effective as longer courses (2-4 weeks). Randomized clinical trials and meta-analyses have demonstrated that single-fraction radiotherapy with 1 x 8 Gy is as effective for pain relief as multi-fraction regimens such as 5 x 4 Gy in 1 week or 10 x 3 Gy in 2 weeks. Re-irradiation for recurrent pain in the irradiated region is required more often after single-fraction radiotherapy than multi-fraction radiotherapy; however, re-irradiation following single-fraction radiotherapy is safe and effective. Thus, 1 x 8 Gy is considered the standard regimen for uncomplicated painful bone metastases without pathological fractures or spinal cord compression. Multi-fraction radiotherapy results in significantly better remineralization of the osteolytic bone than single-fraction radiotherapy. Remineralization is important for preventing or treating pathological fractures. Multi-fraction long-course radiotherapy results in fewer recurrences of spinal-cord compression within the irradiated spinal region. Thus, long-course multi-fraction radiotherapy should be reserved for patients with a relatively favorable survival prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20234353     DOI: 10.1038/nrclinonc.2010.17

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  76 in total

1.  Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.

Authors:  Samuel Ryu; Fang Fang Yin; Jack Rock; Jingeng Zhu; Archie Chu; Eduard Kagan; Lisa Rogers; Munther Ajlouni; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

2.  Combining systemic bisphosphonates with palliative external beam radiotherapy or bone-targeted radionuclide therapy: interactions and effectiveness.

Authors:  V Vassiliou; O Bruland; N Janjan; S Lutz; D Kardamakis; P Hoskin
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-08-22       Impact factor: 4.126

3.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Authors:  William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

4.  Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

Authors:  Dirk Rades; Lukas J A Stalpers; Theo Veninga; Rainer Schulte; Peter J Hoskin; Nermina Obralic; Amira Bajrovic; Volker Rudat; Rudolf Schwarz; Maarten C Hulshof; Philip Poortmans; Steven E Schild
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

5.  Prognostic factors and a scoring system for patients with skeletal metastasis.

Authors:  H Katagiri; M Takahashi; K Wakai; H Sugiura; T Kataoka; K Nakanishi
Journal:  J Bone Joint Surg Br       Date:  2005-05

6.  American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Authors:  James R Berenson; Bruce E Hillner; Robert A Kyle; Ken Anderson; Allan Lipton; Gary C Yee; J Sybil Biermann
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

7.  Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.

Authors:  Lee S Rosen; David Gordon; Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh; M Krzakowski; M Pawlicki; Paul de Souza; Ming Zheng; Gladys Urbanowitz; Dirk Reitsma; John J Seaman
Journal:  J Clin Oncol       Date:  2003-08-15       Impact factor: 44.544

8.  The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome.

Authors:  S K Joishy; D Walsh
Journal:  J Pain Symptom Manage       Date:  1998-11       Impact factor: 3.612

Review 9.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

Review 10.  Clinical experience with strontium-89 in prostatic and breast cancer patients.

Authors:  R G Robinson; D F Preston; K G Baxter; R W Dusing; J A Spicer
Journal:  Semin Oncol       Date:  1993-06       Impact factor: 4.929

View more
  21 in total

Review 1.  MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics.

Authors:  Alberto Bazzocchi; Alessandro Napoli; Beatrice Sacconi; Giuseppe Battista; Giuseppe Guglielmi; Carlo Catalano; Ugo Albisinni
Journal:  Br J Radiol       Date:  2015-11-26       Impact factor: 3.039

2.  A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone.

Authors:  Parisa Hesami; Boris M Holzapfel; Anna Taubenberger; Martine Roudier; Ladan Fazli; Shirly Sieh; Laure Thibaudeau; Laura S Gregory; Dietmar W Hutmacher; Judith A Clements
Journal:  Clin Exp Metastasis       Date:  2014-02-08       Impact factor: 5.150

3.  Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.

Authors:  Bio Joo; Mi-Suk Park; Soo Hyeon Lee; Hye Jin Choi; Seung Tack Lim; Sun Young Rha; Itay Rachmilevitch; Young Han Lee; Jin-Suck Suh
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

4.  Palliative considerations in the surgical treatment of spinal metastases: evaluation of posterolateral decompression combined with posterior instrumentation.

Authors:  Jan Walter; Rupert Reichart; Albrecht Waschke; Rolf Kalff; Christian Ewald
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-30       Impact factor: 4.553

5.  Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience.

Authors:  Yuan Yao; Zhaonan Li; Dechao Jiao; Xueliang Zhou; Jing Li; Xinwei Han
Journal:  Diagn Interv Radiol       Date:  2021-07       Impact factor: 2.630

Review 6.  The role of radiotherapy for metastatic epidural spinal cord compression.

Authors:  Dirk Rades; Janet L Abrahm
Journal:  Nat Rev Clin Oncol       Date:  2010-08-31       Impact factor: 66.675

Review 7.  Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults.

Authors:  Siew Hwa Lee; Robin Grant; Catriona Kennedy; Lynn Kilbride
Journal:  Cochrane Database Syst Rev       Date:  2015-09-24

8.  Palliative stereotactic-endoscopic third ventriculostomy for the treatment of obstructive hydrocephalus from cerebral metastasis.

Authors:  Clark C Chen; Ekkehard Kasper; Peter Warnke
Journal:  Surg Neurol Int       Date:  2011-06-15

9.  Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer.

Authors:  Gregory Hess; Arie Barlev; Karen Chung; Jerrold W Hill; Eileen Fonseca
Journal:  Radiat Oncol       Date:  2012-10-12       Impact factor: 3.481

10.  125I Seed Implant Brachytherapy for Painful Bone Metastases After Failure of External Beam Radiation Therapy.

Authors:  Shi Feng; Li Wang; Zhang Xiao; Rakesh Maharjan; Li Chuanxing; Zhang Fujun; Huang Jinhua; Wu Peihong
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.